Dr. Brzezniak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1860 Town Center Dr
Ste 460
Reston, VA 20190Phone+1 703-437-6535Fax+1 703-437-6549- Is this information wrong?
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2010 - 2012
Dwight David Eisenhower Army Medical CenterResidency, Internal Medicine, 2007 - 2010
Lake Erie College of Osteopathic Medicine - Seton HillClass of 2007
Certifications & Licensure
VA State License 2018 - 2026
NY State License 2008 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 200 citationsSunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trialAnish Thomas, Arun Rajan, Arlene Berman, Yusuke Tomita, Christina Brzezniak
The Lancet. Oncology. 2015-02-01 - 7 citationsA Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient after Priming with RRx-001Bryan Oronsky, Scott Caroen, Karen Zeman, Mary Flanagan Quinn, Christina Brzezniak
Clinical Medicine Insights. Oncology. 2016-11-06 - 67 citationsSelumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer†Corey A. Carter, Arun Rajan, Corrine Keen, Eva Szabo, Sean Khozin
Annals of Oncology. 2016-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
